-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Downgrades Perspective Therapeutics to Sector Perform, Lowers Price Target to $4

Benzinga·10/26/2026 16:05:02
Diffusion vocale
RBC Capital analyst Leonid Timashev downgrades Perspective Therapeutics (AMEX:CATX) from Outperform to Sector Perform and lowers the price target from $14 to $4.